# Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

> **NCT03176173** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 45 (actual)

## Conditions studied

- Stage IV Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Image-guided Radiation Therapy
- **DRUG:** Immunotherapy (physician's choice for standard of care immunotherapy)

## Key facts

- **NCT ID:** NCT03176173
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2021-11-24
- **Final completion:** 2025-01-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03176173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03176173, "Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03176173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*